Celcuity Inc.
(NASDAQ : CELC)

( )
CELC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
EFXEquifax Inc.
0.07%97.192.0%$137.60m
ETSYEtsy, Inc.
-1.29%54.347.9%$129.04m
FLTFleetCor Technologies, Inc.
-1.52%176.943.4%$128.78m
ZZillow Group, Inc. Class C
-1.40%32.3810.3%$127.83m
CTASCintas Corporation
-1.22%169.744.4%$102.44m
BZUNBaozun Inc Sponsored ADR Class A
-1.95%36.151.7%$99.06m
CPRTCopart, Inc.
-2.71%48.044.5%$95.55m
XRXXerox Corporation
-1.29%24.435.6%$89.20m
ITGartner, Inc.
-3.71%138.942.4%$79.51m
TRUTransUnion
-3.74%58.960.9%$78.59m
ULTIUltimate Software Group, Inc.
-2.04%250.699.9%$65.13m
PRAHPRA Health Sciences, Inc.
-3.66%99.722.4%$61.10m
BAHBooz Allen Hamilton Holding Corporation Class A
-2.54%49.091.9%$61.05m
TVPTTravelport Worldwide Ltd.
-0.03%15.700.6%$51.94m
CDKCDK Global Inc
-1.10%47.702.2%$49.75m

Company Profile

Celcuity, Inc. is cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded in January 2012 by Brian Sullivan and Lance Laing and is headquartered in Minneapolis, MN.